| How can airborne transmission of COVID-19 indoors be minimised? L Morawska, JW Tang, W Bahnfleth, PM Bluyssen, A Boerstra, ... Environment international 142, 105832, 2020 | 1555 | 2020 |
| European Respiratory Society guidelines for the management of adult bronchiectasis E Polverino, PC Goeminne, MJ McDonnell, S Aliberti, SE Marshall, ... European Respiratory Journal 50 (3), 2017 | 1274 | 2017 |
| Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study JM Bryant, DM Grogono, D Greaves, J Foweraker, I Roddick, T Inns, ... The Lancet 381 (9877), 1551-1560, 2013 | 791 | 2013 |
| British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) CS Haworth, J Banks, T Capstick, AJ Fisher, T Gorsuch, IF Laurenson, ... Thorax 72 (Suppl 2), ii1-ii64, 2017 | 776 | 2017 |
| British Thoracic Society Guideline for bronchiectasis in adults AT Hill, AL Sullivan, JD Chalmers, A De Soyza, JS Elborn, RA Floto, ... Thorax 74 (Suppl 1), 1-69, 2019 | 664 | 2019 |
| US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis RA Floto, KN Olivier, L Saiman, CL Daley, JL Herrmann, JA Nick, ... Thorax 71 (Suppl 1), i1-i22, 2016 | 635 | 2016 |
| Guide to bone health and disease in cystic fibrosis RM Aris, PA Merkel, LK Bachrach, DS Borowitz, MP Boyle, SL Elkin, ... The Journal of Clinical Endocrinology & Metabolism 90 (3), 1888-1896, 2005 | 589 | 2005 |
| Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium JM Bryant, DM Grogono, D Rodriguez-Rincon, I Everall, KP Brown, ... Science 354 (6313), 751-757, 2016 | 577 | 2016 |
| Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research AT Hill, CS Haworth, S Aliberti, A Barker, F Blasi, W Boersma, ... European Respiratory Journal 49 (6), 2017 | 392 | 2017 |
| Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection M Renna, C Schaffner, K Brown, S Shang, MH Tamayo, K Hegyi, ... The Journal of clinical investigation 121 (9), 2011 | 355 | 2011 |
| Inhaled Colistin in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Infection CS Haworth, JE Foweraker, P Wilkinson, RF Kenyon, D Bilton American journal of respiratory and critical care medicine 189 (8), 975-982, 2014 | 333 | 2014 |
| A paradigm shift to combat indoor respiratory infection L Morawska, J Allen, W Bahnfleth, PM Bluyssen, A Boerstra, G Buonanno, ... Science 372 (6543), 689-691, 2021 | 329 | 2021 |
| Low bone mineral density in adults with cystic fibrosis CS Haworth, PL Selby, AK Webb, ME Dodd, H Musson, RML Niven, ... Thorax 54 (11), 961-967, 1999 | 299 | 1999 |
| Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis JD Chalmers, CS Haworth, ML Metersky, MR Loebinger, F Blasi, O Sibila, ... New England Journal of Medicine 383 (22), 2127-2137, 2020 | 280 | 2020 |
| European cystic fibrosis bone mineralisation guidelines I Sermet-Gaudelus, ML Bianchi, M Garabédian, RM Aris, A Morton, ... Journal of Cystic Fibrosis 10, S16-S23, 2011 | 239 | 2011 |
| The EMBARC European Bronchiectasis Registry: protocol for an international observational study JD Chalmers, S Aliberti, E Polverino, M Vendrell, M Crichton, M Loebinger, ... ERJ open research 2 (1), 2016 | 229 | 2016 |
| Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristics SJ Fowler, J French, NJ Screaton, J Foweraker, A Condliffe, CS Haworth, ... European Respiratory Journal 28 (6), 1204-1210, 2006 | 205 | 2006 |
| Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3 … CS Haworth, D Bilton, JD Chalmers, AM Davis, J Froehlich, I Gonda, ... The lancet Respiratory medicine 7 (3), 213-226, 2019 | 192 | 2019 |
| Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations S Aliberti, PC Goeminne, AE O'Donnell, TR Aksamit, H Al-Jahdali, ... The Lancet Respiratory Medicine 10 (3), 298-306, 2022 | 189 | 2022 |
| Diabetes as a determinant of mortality in cystic fibrosis P Chamnan, BSF Shine, CS Haworth, D Bilton, AI Adler Diabetes care 33 (2), 311-316, 2010 | 179 | 2010 |
